The Alzheimer Society last year presented a report called “Rising Tide: The Impact of Dementia in Canada”, saying that one of the greatest costs to health care in the decades to come will be neurological disorders.
What types of financial commitments are we seeing at CIHR toward an investment in neurological disorders, whether it be MS, autism, Parkinson's, or ALS? I know that around this table there's a great degree of interest in neurological disorders.